Importantly, miR34c seemed to regulate both Bcl2 and NUMB expression, restricting the tumor cell’s ability to avoid apoptosis and potentially enhancing the effectiveness of chemo/radiotherapies for GBM treatment [71] and prompting miR34 family members to be considered as potential GBM therapy. Here, BCL2 is linked to glioblastoma.